medigraphic.com
ISSN 2992-8036 (Digital)
ISSN 2306-4102 (Impreso)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2013, Número S1

<< Anterior Siguiente >>

Acta Ortop Mex 2013; 27 (S1)


Tratamiento con antibióticos y tiempo adecuado para realizar una artroplastía de recambio

Idioma: Español
Referencias bibliográficas: 51
Paginas: 138-142
Archivo PDF: 118.08 Kb.


FRAGMENTO

Pregunta 1: ¿Se puede utilizar antibioticoterapia por vía oral en lugar de intravenosa para el tratamiento inicial de una infección articular periprotésica (IAP) inmediatamente después de retirar el implante?

Consenso: Existen evidencias para apoyar la antibioticoterapia oral como una opción en el tratamiento de la IAP por su alta biodisponibilidad y porque puede atacar específicamente al agente patógeno.
Voto de los delegados: de acuerdo, 79%; en desacuerdo, 11%; abstenciones, 1%. (Consenso fuerte.)


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Farhad R, Roger PM, Albert C, et al: Six weeks antibiotic therapy for all bone infections: results of a cohort study. Eur J Clin Microbiol Infect Dis. 2010; 29(2): 217-222.

  2. Gómez J, Canovas E, Baños V, et al: Linezolid plus rifampin as a salvage therapy in prosthetic joint infections treated without removing the implant. Antimicrob Agents Chemother. 2011; 55(9): 4308-4310.

  3. Peel TN, Buising KL, Dowsey MM, et al: Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy. Antimicrob Agents Chemother. 2013; 57(1): 350-355.

  4. Toma MB, Smith KM, Martin CA, Rapp RP: Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. Orthopedics. 2006; 29(6): 497-501.

  5. Trampuz A, Zimmerli W: Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs. 2006; 66(8): 1089-1105.

  6. Stockley I, Mockford BJ, Hoad-Reddick A, Norman P: The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br. 2008; 90(2): 145-148.

  7. Osmon DR, Berbari EF, Berendt AR, et al: Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013; 56(1): e1-e25.

  8. Bertazzoni-Minelli E, Caveiari C, Benini A: Release of antibiotics from polymethylmethacrylate cement. J Chemother. 2002; 14(5): 492-500.

  9. Dubee V, Zeller V, Lhotellier L, et al: Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study. Clin Microbiol Infect. 2013; 19(2): E98-105.

  10. Masri BA, Panagiotopoulos KP, Greidanus NV, Garbuz DS, Duncan CP: Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. J Arthroplasty. 2007; 22(1): 72-78.

  11. Darley ES, Bannister GC, Blom AW, Macgowan AP, Jacobson SK, Alfouzan W: Role of early intravenous to oral antibiotic switch therapy in the management of prosthetic hip infection treated with one- or two-stage replacement. J Antimicrob Chemother. 2011; 66(10): 2405-2408.

  12. Esposito S, Esposito I, Leone S: Considerations of antibiotic therapy duration in community- and hospital-acquired bacterial infections. J Antimicrob Chemother. 2012; 67(11): 2570-2575.

  13. Hsieh PH, Shih CH, Chang YH, Lee MS, Shih HN, Yang WE: Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg Am. 2004; 86-A(9): 1989-1997.

  14. McKenna PB, O’Shea K, Masterson EL: Two-stage revision of infected hip arthroplasty using a shortened post-operative course of antibiotics. Arch Orthop Trauma Surg. 2009; 129(4): 489-494.

  15. Senthi S, Munro JT, Pitto RP: Infection in total hip replacement: meta-analysis. Int Orthop. 2011; 35(2): 253-260.

  16. Whittaker JP, Warren RE, Jones RS, Gregson PA: Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection? J Bone Joint Surg Br. 2009; 91(1): 44-51.

  17. Bernard L, Legout L, Zurcher-Pfund L, et al: Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty. J Infect. 2010; 61(2): 125-132.

  18. Glassman AH, Lachiewicz PF, Tanzer M, eds: Orthopaedic knowledge update 4: hip and knee reconstruction. 4th ed. American Academy of Orthopaedics; 2011.

  19. Kusuma SK, Ward J, Jacofsky M, Sporer SM, Della Valle CJ: What is the role of serological testing between stages of two-stage reconstruction of the infected prosthetic knee? Clin Orthop Relat Res. 2011; 469(4): 1002-1008.

  20. Larsson S, Thelander U, Friberg S: C-reactive protein (CRP) levels after elective orthopedic surgery. Clin Orthop Relat Res. 1992; (275): 237-242.

  21. Schinsky MF, Della Valle CJ, Sporer SM, Paprosky WG: Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty. J Bone Joint Surg Am. 2008; 90(9): 1869-1875.

  22. Shukla SK, Ward JP, Jacofsky MC, Sporer SM, Paprosky WG, Della Valle CJ: Perioperative testing for persistent sepsis following resection arthroplasty of the hip for periprosthetic infection. J Arthroplasty. 2010; 25(Suppl 6): 87-91.

  23. Spangehl MJ, Masri BA, O’Connell JX, Duncan CP: Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am. 1999; 81(5): 672-683.

  24. Ghanem E, Antoci V Jr, Pulido L, Joshi A, Hozack W, Parvizi J: The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis. 2009; 13(6): e444-449.

  25. Pundiche M, Sarbu V, Unc OD, et al: Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients. Chirurgia (Bucur). 2012; 107(1): 71-78.

  26. Jacovides CL, Parvizi J, Adeli B, Jung KA: Molecular markers for diagnosis of periprosthetic joint infection. J Arthroplasty. 2011; 26(Suppl 6): 99-103 e101.

  27. Parvizi J, Jacovides C, Antoci V, Ghanem E: Diagnosis of periprosthetic joint infection: the utility of a simple yet unappreciated enzyme. J Bone Joint Surg Am. 2012; 93(24): 2242-2248.

  28. Parvizi J, Walinchus L, Adeli B: Molecular diagnostics in periprosthetic joint infection. Int J Artif Organs. 2011; 34(9): 847-855.

  29. Deirmengian C, Hallab N, Tarabishy A, et al: Synovial fluid biomarkers for periprosthetic infection. Clin Orthop Relat Res. 2010; 468(8): 2017-2023.

  30. Bejon P, Berendt A, Atkins BL, et al: Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. J Antimicrob Chemother. 2010; 65(3): 569-575.

  31. Hozack WJ, Parvizi J: New definition for periprosthetic joint infection. J Arthroplasty. 2011; 26(8): 1135.

  32. Parvizi J: New definition for periprosthetic joint infection. Am J Orthop (Belle Mead NJ). 2011; 40(12): 614-615.

  33. Parvizi J, Zmistowski B, Berbari EF, et al: New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011; 469(11): 2992-2994.

  34. Esposito S, Leone S, Bassetti M, et al: Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults. Infection. 2009; 37(6): 478-496.

  35. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE: Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998; 279(19): 1537-1541.

  36. Zimmerli W, Trampuz A, Ochsner PE: Prosthetic-joint infections. N Engl J Med. 2004; 351(16): 1645-1654.

  37. San Juan R, Garcia-Reyne A, Caba P, et al: Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infections. Antimicrob Agents Chemother. 2010; 54(12): 5161-5166.

  38. Forrest GN, Tamura K: Rifampin combination therapy for nonmycobacterial infections. Clin Microbiol Rev. 2010; 23(1): 14-34.

  39. Lai CC, Tan CK, Lin SH, Liao CH, Huang YT, Hsueh PR: Emergence of rifampicin resistance during rifampicin-containing treatment in elderly patients with persistent methicillin-resistant Staphylococcus aureus bacteremia. J Am Geriatr Soc. 2010; 58(5): 1001-1003.

  40. Achermann Y, Eigenmann K, Ledergerber B, et al: Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study. Infection. 2013; 41(2): 431-437.

  41. Rudelli S, Uip D, Honda E, Lima AL: One-stage revision of infected total hip arthroplasty with bone graft. J Arthroplasty. 2008; 23(8): 1165-1177.

  42. Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F: One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg Br. 2008; 90(12): 1580-1584.

  43. Yoo JJ, Kwon YS, Koo KH, Yoon KS, Kim YM, Kim HJ: One-stage cementless revision arthroplasty for infected hip replacements. Int Orthop. 2009; 33(5): 1195-1201.

  44. Whiteside LA, Nayfeh TA, LaZear R, Roy ME: Reinfected revised TKA resolves with an aggressive protocol and antibiotic infusion. Clin Orthop Relat Res. 2012; 470(1): 236-243.

  45. Whiteside LA, Peppers M, Nayfeh TA, Roy ME: Methicillin-resistant Staphylococcus aureus in TKA treated with revision and direct intra-articular antibiotic infusion. Clin Orthop Relat Res. 2011; 469(1): 26-33.

  46. Choi HR, Kwon YM, Freiberg AA, Nelson SB, Malchau H: Periprosthetic joint infection with negative culture results: clinical characteristics and treatment outcome. J Arthroplasty. 2013; 28(6): 899-903.

  47. Huang R, Hu CC, Adeli B, Mortazavi J, Parvizi J: Culture-negative periprosthetic joint infection does not preclude infection control. Clin Orthop Relat Res. 2012; 470(10): 2717-2723.

  48. Marschall J, Lane MA, Beekmann SE, Polgreen PM, Babcock HM: Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey. Int J Antimicrob Agents. 2013; 41(3): 272-277.

  49. Ghanem E, Azzam K, Seeley M, Joshi A, Parvizi J: Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? Clin Orthop Relat Res. 2009; 467(7): 1699-1705.

  50. Lonner JH, Siliski JM, Della Valle C, DiCesare P, Lotke PA: Role of knee aspiration after resection of the infected total knee arthroplasty. Am J Orthop (Belle Mead NJ). 2001; 30(4): 305-309.

  51. Mont MA, Waldman BJ, Hungerford DS: Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection. A comparison-group study. J Bone Joint Surg Am. 2000; 82-A(11): 1552-1557.




2020     |     www.medigraphic.com